These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38034017)

  • 21. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
    Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
    Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
    [No Abstract]   [Full Text] [Related]  

  • 22. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Andrographolide Inhibits Ovariectomy-Induced Bone Loss via the Suppression of RANKL Signaling Pathways.
    Wang T; Liu Q; Zhou L; Yuan JB; Lin X; Zeng R; Liang X; Zhao J; Xu J
    Int J Mol Sci; 2015 Nov; 16(11):27470-81. PubMed ID: 26593901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways.
    Li X; Lin X; Wu Z; Su Y; Liang J; Chen R; Yang X; Hou L; Zhao J; Liu Q; Xu F
    Drug Des Devel Ther; 2021; 15():61-74. PubMed ID: 33442237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
    Qian Z; Zhong Z; Ni S; Li D; Zhang F; Zhou Y; Kang Z; Qian J; Yu B
    J Cell Mol Med; 2020 Sep; 24(17):10112-10127. PubMed ID: 32790170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (
    Ding M; Cho E; Chen Z; Park SW; Lee TH
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumambrin A prevents OVX-induced osteoporosis
    Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
    FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (-)-Epicatechin 3-O-β-D-allopyranoside prevent ovariectomy-induced bone loss in mice by suppressing RANKL-induced NF-κB and NFATc-1 signaling pathways.
    Hsiao HB; Wu JB; Lin WC
    BMC Complement Altern Med; 2017 May; 17(1):245. PubMed ID: 28468652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of RIPK1/RIPK3 ameliorates osteoclastogenesis through regulating NLRP3-dependent NF-κB and MAPKs signaling pathways.
    Liang S; Nian Z; Shi K
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1028-1035. PubMed ID: 32321638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation.
    Zhuang J; Ning H; Wang M; Zhao W; Jing Y; Liu X; Zu J; Kong P; Wang X; Sun C; Yan J
    Cell Signal; 2021 Nov; 87():110137. PubMed ID: 34469786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells.
    Pengjam Y; Madhyastha H; Madhyastha R; Yamaguchi Y; Nakajima Y; Maruyama M
    Phytomedicine; 2016 Apr; 23(4):417-28. PubMed ID: 27002412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isosinensetin alleviates estrogen deficiency-induced osteoporosis via suppressing ROS-mediated NF-κB/MAPK signaling pathways.
    Qin Y; Song D; Liao S; Chen J; Xu M; Su Y; Lian H; Peng H; Wei L; Chen K; Xu J; Zhao J; Liu Q
    Biomed Pharmacother; 2023 Apr; 160():114347. PubMed ID: 36746095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
    Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
    J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
    Cheng J; Zhou L; Liu Q; Tickner J; Tan Z; Li X; Liu M; Lin X; Wang T; Pavlos NJ; Zhao J; Xu J
    J Cell Physiol; 2018 Mar; 233(3):2502-2512. PubMed ID: 28771720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-κB pathway.
    Ren Y; Zhang K; Wang J; Meng X; Du X; Shi Z; Xue Y; Hong W
    Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):201-211. PubMed ID: 33404645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corylifol A protects against ovariectomized-induced bone loss and attenuates RANKL-induced osteoclastogenesis via ROS reduction, ERK inhibition, and NFATc1 activation.
    Xu Y; Song D; Lin X; Peng H; Su Y; Liang J; Hai N; Zhao J; Liu Q
    Free Radic Biol Med; 2023 Feb; 196():121-132. PubMed ID: 36649902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-κB pathway.
    Wang F; Zhang C; Ge W; Zhang G
    J Cell Mol Med; 2019 Oct; 23(10):6744-6754. PubMed ID: 31402549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.